CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

BioSpace
Original article

No deal between AstraZeneca and BMS, senior source insists: Reuters

Negative
AI Analysis

Summary

Reuters reports that AstraZeneca and Bristol Myers Squibb are not in merger discussions, contradicting industry speculation about a potential blockbuster pharma deal. A senior source denied claims of active negotiations between the two companies.

Outcome Details

Merger discussions denied by senior source

Importance:6/10
Sentiment:
-0.30
M&Amerger_rumor_deniedpharma_industry
Related Companies

Read the original article

Published by BioSpace on August 5, 2026 2:57 PM

Read Original